ANVIS Migraine

Description

ANVIS Migraine is a combination tablet product whose original carton names paracetamol, meloxicam, domperidone and caffeine. The photographed presentation contains thirty tablets. This page identifies the labelled combination and its pack format without assuming a suitable dose or treatment plan.

ANVIS Migraine product specification

• Labelled ingredients: Paracetamol, meloxicam, domperidone and caffeine
• Strength information: Confirm individual ingredient amounts and directions on the complete supplied label
• Dosage form: Tablets
• Pack presentation: 3 × 10 tablets (30 tablets)
• Brand: ANVIS

Understanding the combination

Meloxicam is a nonsteroidal anti-inflammatory medicine, also called an NSAID. Domperidone is an anti-sickness medicine. However, information about either ingredient alone does not establish every use of this exact combination. First, ask a qualified clinician whether the complete formulation is appropriate for your symptoms.

The product name refers to migraine, but a name cannot confirm the cause of a headache. Also, the carton quantity does not determine how often to take a tablet. Confirm each ingredient amount on the full label and follow the prescription and product leaflet. Do not choose a regimen from a catalogue photograph.

Important precautions

Meloxicam can cause serious stomach bleeding and may increase heart attack or stroke risk. Therefore, discuss ulcers, bleeding, heart disease and kidney problems before use. Also ask before combining it with aspirin, ibuprofen or another NSAID. Seek individual advice during pregnancy or breastfeeding.

Domperidone requires particular care in people with heart rhythm problems. Tell your clinician about all medicines and any liver or heart condition. In addition, check other pain and cold products for paracetamol to avoid overlapping ingredients. The complete leaflet provides further precautions for the combination.

Get urgent medical help for chest pain, breathing difficulty or signs of stomach bleeding. These examples do not list every possible reaction. Ask a pharmacist to explain the warning information before starting treatment.

Documentation and enquiries

For general ingredient background, read the MedlinePlus meloxicam guide. However, that source does not confirm the full specification of this ANVIS product. For further documentation or availability, contact ANVIS with the exact name and pack presentation. Alternatively, browse the ANVIS product catalogue to compare other products.

For domperidone precautions, also read the NHS domperidone guidance.